Abstract |
Hydroxychloroquine is being investigated for a potential prophylactic effect in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but its mechanism of action is poorly understood. Circulating leukocytes from the blood of coronavirus disease 2019 (COVID-19) patients show increased responses to Toll-like receptor ligands, suggestive of trained immunity. By analyzing interferon responses of peripheral blood mononuclear cells from healthy donors conditioned with heat-killed Candida, trained innate immunity can be modeled in vitro. In this model, hydroxychloroquine inhibits the responsiveness of these innate immune cells to virus-like stimuli and interferons. This is associated with a suppression of histone 3 lysine 27 acetylation and histone 3 lysine 4 trimethylation of inflammation-related genes, changes in the cellular lipidome, and decreased expression of interferon-stimulated genes. Our findings indicate that hydroxychloroquine inhibits trained immunity in vitro, which may not be beneficial for the antiviral innate immune response to SARS-CoV-2 infection in patients.
|
Authors | Nils Rother, Cansu Yanginlar, Rik G H Lindeboom, Siroon Bekkering, Mandy M T van Leent, Baranca Buijsers, Inge Jonkman, Mark de Graaf, Marijke Baltissen, Lieke A Lamers, Niels P Riksen, Zahi A Fayad, Willem J M Mulder, Luuk B Hilbrands, Leo A B Joosten, Mihai G Netea, Michiel Vermeulen, Johan van der Vlag, Raphaël Duivenvoorden |
Journal | Cell reports. Medicine
(Cell Rep Med)
Vol. 1
Issue 9
Pg. 100146
(12 22 2020)
ISSN: 2666-3791 [Electronic] United States |
PMID | 33377122
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 The Authors. |
Chemical References |
- Hydroxychloroquine
- Interferons
|
Topics |
- COVID-19
(immunology)
- Epigenesis, Genetic
(drug effects)
- Humans
- Hydroxychloroquine
(pharmacology, therapeutic use)
- Immunity, Innate
(drug effects)
- Immunologic Memory
(drug effects)
- Immunomodulation
- Interferons
(immunology)
- Leukocytes, Mononuclear
(drug effects, immunology, metabolism)
- Lipid Metabolism
(drug effects)
- SARS-CoV-2
- Severity of Illness Index
- COVID-19 Drug Treatment
|